Tranylcypromine clinical trials
Also written Parnate.
How each study uses Tranylcypromine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 21 Feb 1961 · PARNATE · NDA 012342 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 2015 (3)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 9
New York State Psychiatric Institute (3) · TC Erciyes University (1) · University of Miami (1) · Vanderbilt University (1) · Par Pharmaceutical, Inc. (1) · Hannover Medical School (1) · Michael Luebbert (1) · Martin-Luther-Universität Halle-Wittenberg (1)
Often tested with
Tested in the same studies.
Tretinoin (3) · Diphenhydramine (2) · Rivastigmine (2) · Atomoxetine (1) · Acarbose (1) · Pyridostigmine (1) · Yohimbine (1) · Midodrine (1)
Related medicines
As reviewed, each with the page that says it.
- One of MAO inhibitors (MAOIs) source
Studies
Open first, then newest update. How each study uses Tranylcypromine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 10
- The Effect of Tranexamic Acid in Endoscopic and Microscopic Ear Surgery Cases on Surgeon SatisfactionCompletedNot applicableTC Erciyes UniversityNCT06434636Written as Transamine 10% IV/IM Solution for InjectionHow we know
- Study of TCP-ATRA for Adult Patients With AML and MDSCompletedPhase 1University of MiamiNCT02273102Written as TranylcypromineHow we know
- Study of Sensitization of Non-M3 AML Blasts to ATRA by Epigenetic Treatment With Tranylcypromine (TCP)Status unknownPhase 1/2Michael LuebbertNCT02717884Written as tranylcypromineHow we know
- Tranylcypromine Treatment of Bipolar DepressionCompletedPhase 4New York State Psychiatric InstituteNCT01430455Written as TranylcypromineHow we know
- Pharmacovigilance in Gerontopsychiatric PatientsTerminatedPhase 3Hannover Medical SchoolNCT02374567Written as TranylcypromineHow we know
- Treatment of Orthostatic Hypotension in Autonomic FailureCompletedPhase 1Vanderbilt UniversityNCT00223691Written as TranylcypromineHow we know
- Phase I/II Trial of ATRA and TCP in Patients With Relapsed or Refractory AML and no Intensive Treatment is PossibleStatus unknownPhase 1/2Martin-Luther-Universität Halle-WittenbergNCT02261779Written as TranylcypromineHow we know
- PET Biomarkers in Treatment Resistant DepressionTerminatedPhase 4New York State Psychiatric InstituteNCT01031810Written as tranylcypromineHow we know
- Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory DepressionTerminatedPhase 4New York State Psychiatric InstituteNCT00296686Written as TranylcypromineHow we know
- Bioavailability Study of Tranylcypromine 10mg Tablets Under Fasting ConditionsCompletedPhase 1Par Pharmaceutical, Inc.NCT00653393Written as TranylcypromineHow we know
Given beside what is tested · 1 — Tranylcypromine is usual care or a partner of the new treatment
Codes
What other systems call Tranylcypromine · ClinicalTrials.gg INT008343
- MeSH (NLM) D014191TranylcypromineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 3E3V44J4Z9TRANYLCYPROMINEConfirmed FDA, NLM, Wikidata
- RxNorm 10734Confirmed FDA, Wikidata
- Wikidata Q100429273trans-(+)-tranylcypromineConfirmed FDA, NLM, Wikidata
- Wikidata Q420885tranylcypromineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61979TranylcypromineOne source FDA
- DrugBank DB00752One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D014191 | Tranylcypromine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 3E3V44J4Z9 | TRANYLCYPROMINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 10734 | — | Confirmed FDA, Wikidata |
| Wikidata | Q100429273 | trans-(+)-tranylcypromine | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q420885 | tranylcypromine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61979 | Tranylcypromine | One source FDA |
| DrugBank | DB00752 | — | One source Wikidata |
Also registered as tranylcypromine sulfate (UNII 7ZAT6ES870 · RxNorm 91119).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.